Beijing Beilu Pharmaceutical (300016) — Financial Flexibility Index
Beijing Beilu Pharmaceutical (300016) has a Financial Flexibility Index of 0.16x as of September 2025. Free cash flow of CN¥132.62 Million (operating CF CN¥74.66 Million minus capex CN¥57.96 Million) represents 0% of total liabilities (CN¥852.80 Million). Check 300016 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Beijing Beilu Pharmaceutical Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Beijing Beilu Pharmaceutical across 19 annual periods. See working capital to net assets of Beijing Beilu Pharmaceutical to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Beijing Beilu Pharmaceutical (2006–2024)
Year-by-year free cash flow to debt coverage for Beijing Beilu Pharmaceutical. For the full company profile including market capitalisation, see 300016 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.23x | CN¥264.41 Million | CN¥163.02 Million | CN¥1.15 Billion | ▲ +17.2% |
| 2023 | 0.20x | CN¥203.07 Million | CN¥58.46 Million | CN¥1.03 Billion | ▼ -23.9% |
| 2022 | 0.26x | CN¥230.60 Million | CN¥127.81 Million | CN¥892.27 Million | ▼ -17.6% |
| 2021 | 0.31x | CN¥256.48 Million | CN¥108.73 Million | CN¥818.22 Million | ▼ -14.0% |
| 2020 | 0.36x | CN¥348.10 Million | CN¥176.00 Million | CN¥955.50 Million | ▼ -67.1% |
| 2019 | 1.11x | CN¥191.80 Million | CN¥156.81 Million | CN¥173.31 Million | ▼ -60.1% |
| 2018 | 2.77x | CN¥229.81 Million | CN¥175.75 Million | CN¥82.93 Million | ▼ -0.7% |
| 2017 | 2.79x | CN¥199.92 Million | CN¥144.92 Million | CN¥71.65 Million | ▲ +26.1% |
| 2016 | 2.21x | CN¥120.37 Million | CN¥76.17 Million | CN¥54.40 Million | ▲ +73.1% |
| 2015 | 1.28x | CN¥150.09 Million | CN¥80.85 Million | CN¥117.39 Million | ▲ +261.6% |
| 2014 | 0.35x | CN¥85.09 Million | CN¥42.11 Million | CN¥240.67 Million | ▼ -71.9% |
| 2013 | 1.26x | CN¥76.85 Million | CN¥41.37 Million | CN¥61.16 Million | ▼ -13.2% |
| 2012 | 1.45x | CN¥86.32 Million | CN¥22.86 Million | CN¥59.64 Million | ▼ -38.1% |
| 2011 | 2.34x | CN¥77.60 Million | CN¥45.73 Million | CN¥33.19 Million | ▼ -80.4% |
| 2010 | 11.92x | CN¥89.29 Million | CN¥37.51 Million | CN¥7.49 Million | ▲ +232.0% |
| 2009 | 3.59x | CN¥63.23 Million | CN¥57.91 Million | CN¥17.60 Million | ▲ +2616.7% |
| 2008 | -0.14x | CN¥-3.78 Million | CN¥-4.76 Million | CN¥26.52 Million | ▼ -158.6% |
| 2007 | 0.24x | CN¥12.50 Million | CN¥12.28 Million | CN¥51.36 Million | ▼ -37.7% |
| 2006 | 0.39x | CN¥21.15 Million | CN¥19.65 Million | CN¥54.10 Million | — |